04 October 2020

Linesight adds Life Sciences executive to expand North American reach

Multinational construction consultancy firm, Linesight, has announced the addition of
a senior executive to its Life Sciences team in order to expand the company’s footprint in North America and address growing customer needs in the sector. Gul Dusi has joined as Project Director of Life Sciences and will be based in Linesight’s San Francisco offices. Gul will work closely with Jeff Peragallo, Director of Life Sciences - USA, and Nigel Barnes, Director of Life Sciences - EMEA, who joined the company in early 2019. Since the appointment of Jeff and Nigel, we have grown our Life Sciences business exponentially and have expanded our service offering for our clients. 

Patrick Ryan, EVP Americas, Linesight said,

“Gul brings 20 years’ Life Sciences construction expertise and experience to Linesight, and will be a huge asset to our growing team, both here in the US and globally. Gul has strong technical and practical knowledge of large-scale, complex pharmaceutical and healthcare construction programs, which will benefit our clients and partners in North America. We are thrilled to have been able to attract Gul to our team - she will be a strong addition to an already accomplished Life Sciences bench that we continue to build. We are looking forward to immersing her into the Linesight culture.” 

Prior to joining Linesight, Gul spent the past three years as Head of Design and Construction for Global Supply Chain for Edwards Lifesciences. While there, Gul was responsible for all design and construction projects for Edwards manufacturing sites around the globe, from inception of the budget to completion of the project. Gul’s role will be to support Linesights’ clients’ CAPEX investment decisions, and oversee projects during design and construction for successful outcomes. Gul is a strong addition to an already accomplished bench of Life Sciences executives in Linesight.  

Linesight is rapidly expanding its life Sciences business globally, and has a strategic imperative to respond to the needs of its local and multinational clients. The company is involved in a number of exciting complex construction projects across multiple sub-sectors of the industry, including pharmaceutical, bio-technology and medtech. 

 

For more information please contact: 

Fiona D'Arcy, Linesight  

T: +353 (0)87 280 8828

E: fiona.darcy@linesight.com